prof. MUDr. Jiří Mayer, CSc.
Professor, Department of Internal Medicine, Hematology and Oncology
correspondence Address:
Jihlavská 340/20, 625 00 Brno
phone: | +420 532 23 3643, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 1666
2025
-
Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia
American Journal of Hematology, year: 2025, DOI
-
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study
American Journal of Hematology, year: 2025, volume: 100, edition: 3, DOI
-
Endoplasmic reticulum stress disrupts signaling via altered processing of transmembrane receptors
Cell Communication and Signaling, year: 2025, volume: 23, edition: 1, DOI
-
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report
American Journal of Hematology, year: 2025, volume: 100, edition: 3, DOI
-
Robust acute myeloid leukemia engraftment in humanized scaffolds using injectable biomaterials and intravenous xenotransplantation
Molecular oncology, year: 2025, DOI
-
Single or Double Induction With 7+3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia
Journal of clinical oncology, year: 2025, volume: 43, edition: 1, DOI
-
Total psoriasis regression in a patient with chronic myeloid leukemia treated using nilotinib
Annals of Hematology, year: 2025, DOI
2024
-
AKCELEROVANÁ FÁZE BY MĚLA BÝT SOUČÁSTÍ KLASIFIKACE CHRONICKÉ MYELOIDNÍ LEUKEMIE I V ÉŘE EXISTENCE INHIBITORŮ TYROZINKINÁZ
Year: 2024, type: Conference abstract
-
ANALYSIS OF ALTERNATIVE THERAPEUTIC OPTIONS FOR ACUTE MYELOID LEUKEMIA PATIENTS RESISTANT TO VENETOCLAX BASED ON DRUG SCREENING AND EXPRESSION PROFILING
Year: 2024, type: Conference abstract
-
Asciminib add-on to imatinib demonstrates sustained high rates of ongoing therapy and deep molecular responses with prolonged follow-up in the ASC4MORE study
JOURNAL OF HEMATOLOGY & ONCOLOGY, year: 2024, volume: 17, edition: 1, DOI